105 related articles for article (PubMed ID: 17970082)
1. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
[TBL] [Abstract][Full Text] [Related]
2. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
4. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
7. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer.
Nakayama G; Kodera Y; Ohashi N; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2011 May; 31(5):1643-6. PubMed ID: 21617221
[TBL] [Abstract][Full Text] [Related]
8. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
10. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer.
Sakamoto J; Fujiya M; Okamoto K; Nata T; Inaba Y; Moriichi K; Tanabe H; Mizukami Y; Watari J; Ashida T; Kohgo Y
Cancer Epidemiol; 2010 Apr; 34(2):194-9. PubMed ID: 20129840
[TBL] [Abstract][Full Text] [Related]
11. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
[TBL] [Abstract][Full Text] [Related]
12. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value.
Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J
Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma].
Wang CC; Mao WM; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
[TBL] [Abstract][Full Text] [Related]
17. Vimentin methylation as a marker for advanced colorectal carcinoma.
Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
Hibi K; Nakao A
Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
[TBL] [Abstract][Full Text] [Related]
19. p16 gene methylation in colorectal cancers associated with Duke's staging.
Yi J; Wang ZW; Cang H; Chen YY; Zhao R; Yu BM; Tang XM
World J Gastroenterol; 2001 Oct; 7(5):722-5. PubMed ID: 11819863
[TBL] [Abstract][Full Text] [Related]
20. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]